Diasorin | Italy
Dr. Paolo Nunzio Ingallinella is a distinguished biotech director at Diasorin Italia Spa, with over many years of expertise in peptide and protein chemistry for therapeutic and diagnostic applications. he holds a master’s degree in chemistry from the university of naples and began his career at irbm, where he contributed to groundbreaking antiviral research, developing potent hcv peptide inhibitors and an hiv fusion inhibitor that advanced antiviral drug design. He has been leading innovative diagnostic projects at diasorin, including the development of the first automated immunoassays for hdv and hev antibodies and Diagnostics broad-spectrum legionella antigen detection systems. his extensive research portfolio includes 25 completed or ongoing projects, 23 journal publications indexed, and 20 patents published or under process. According to scopus metrics, Dr. Ingallinella has an h-index of 19 with a total of 1,616 citations, reflecting his strong influence in the biotechnology and immunodiagnostics fields. his work focuses on recombinant protein and monoclonal antibody development, biomarker discovery, and molecular biology applications in diagnostics and therapeutic peptide chemistry. A member of the Italian peptide society, Dr. Ingallinella continues to shape the landscape of modern biotechnology through innovation and scientific leadership.
Profile: Scopus
Featured Publications
Ingallinella, P. N., et al. (2025). The LIAISON® Legionella Urinary Ag assay: A novel high-throughput, fully automated dual-antigen detection method with improved sensitivity and expanded Legionella species and serogroup coverage. Respiratory Investigation.
Ingallinella, P. N., et al. (2014). Development of a neuromedin U–human serum albumin conjugate as a long-acting candidate for the treatment of obesity and diabetes: Comparison with the PEGylated peptide. Journal of Peptide Science.
Ingallinella, P. N., et al. (2013). A PEGylated analog of the gut hormone oxyntomodulin with long-lasting antihyperglycemic, insulinotropic, and anorexigenic activity. Bioorganic & Medicinal Chemistry.